Key result
Inclusion of a 12-lead ECG in preparticipation screening improved sensitivity for detecting important cardiac abnormalities from 45.5% to 90.9% compared to screening without ECG.
Absolute Event Rate: 90.9% vs 45.5%
This letter discusses the scientific debate surrounding preparticipation cardiovascular screening for athletes, specifically the utility and implications of including a 12-lead ECG.
Letters20 July 2010Electrocardiography and Preparticipation Screening of Competitive High School AthletesAntonio Pelliccia, MD and Domenico Corrado, MD, PhDAntonio Pelliccia, MDFrom Institute of Sport Medicine and Science, I-00197 Rome, Italy, and University of Padua Medical School, 35121 Padua, Italy. and Domenico Corrado, MD, PhDFrom Institute of Sport Medicine and Science, I-00197 Rome, Italy, and University of Padua Medical School, 35121 Padua, Italy.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-153-2-201007200-00015 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:The editorial by Maron (1), as well as the articles by Baggish and colleagues (2) and Wheeler and colleagues (3), have interesting implications regarding the scientific debate about preparticipation cardiovascular screening for athletes. Baggish and colleagues (2) compared a screening protocol with or without 12-lead ECG in a cohort of U.S. collegiate athletes and showed that inclusion of the ECG improved sensitivity for detecting important cardiac abnormalities from 45.5% to 90.9% and altered the negative predictive value of screening from 98.7% to 99.8%. Wheeler and colleagues (3) assessed the costs and survival rates in U.S. athletes who ...References1. Maron BJ. National electrocardiography screening for competitive athletes: feasible in the United States? [Editorial]. Ann Intern Med. 2010;152:324-6. [PMID: 20194239] LinkGoogle Scholar2. Baggish AL, Hutter AM, Wang F, Yared K, Weiner RB, Kupperman E, et al. Cardiovascular screening in college athletes with and without electrocardiography. A cross-sectional study. Ann Intern Med. 2010;152:269-75. [PMID: 20194232] LinkGoogle Scholar3. Wheeler MT, Heidenreich PA, Froelicher VF, Hlatky MA, Ashley EA. Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes. Ann Intern Med. 2010;152:276-86. [PMID: 20194233] LinkGoogle Scholar4. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296:1593-601. [PMID: 17018804] CrossrefMedlineGoogle Scholar5. Pelliccia A, Di Paolo FM, Corrado D, Buccolieri C, Quattrini FM, Pisicchio C, et al. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J. 2006;27:2196-200. [PMID: 16831826] CrossrefMedlineGoogle Scholar6. Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, et al; American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007;115:1643-455. [PMID: 17353433] MedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Institute of Sport Medicine and Science, I-00197 Rome, Italy, and University of Padua Medical School, 35121 Padua, Italy.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoNational Electrocardiography Screening for Competitive Athletes: Feasible in the United States? Barry J. Maron Cardiovascular Screening in College Athletes With and Without Electrocardiography Aaron L. Baggish , Adolph M. Hutter Jr. , Francis Wang , Kibar Yared , Rory B. Weiner , Eli Kupperman , Michael H. Picard , and Malissa J. Wood Cost-Effectiveness of Preparticipation Screening for Prevention of Sudden Cardiac Death in Young Athletes Matthew T. Wheeler , Paul A. Heidenreich , Victor F. Froelicher , Mark A. Hlatky , and Euan A. Ashley Electrocardiography and Preparticipation Screening of Competitive High School Athletes Barry J. Maron Electrocardiography and Preparticipation Screening of Competitive High School Athletes Joseph C. Marek Metrics Cited ByAssessment of the 12-Lead ECG as a Screening Test for Detection of Cardiovascular Disease in Healthy General Populations of Young People (12–25 Years of Age)Assessment of the 12-Lead Electrocardiogram as a Screening Test for Detection of Cardiovascular Disease in Healthy General Populations of Young People (12–25 Years of Age) 20 July 2010Volume 153, Issue 2Page: 132KeywordsCardiomyopathiesConflicts of interestElectrocardiographyHealth careSports ePublished: 20 July 2010 Issue Published: 20 July 2010 CopyrightCopyright © 2010 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...
No takes yet. Share an insight, caveat, or question.
Antonio Pelliccia (2010) conducted a letter in cardiovascular abnormalities in athletes. 12-lead ECG vs. Screening without 12-lead ECG was evaluated on Sensitivity for detecting important cardiac abnormalities. Inclusion of a 12-lead ECG in preparticipation screening improved sensitivity for detecting important cardiac abnormalities from 45.5% to 90.9% compared to screening without ECG.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: